• Fri news: Gilead withdraws bladder cancer drug. Amgen and Intercept PDUFA date pushback. CVS replaces CEO. Supernus depression trial. AbbVie Parkinson’s approval. See more on our front page

Can we please start talking about Gilead and not Idenix

I wasn't going to comment, but your ignorance is amazing. Merck has 12-16 months until they compete with the same compounds you will have. Enjoy the year to yourself, doctors are still going to hold patients and your company will ride your A$$

Obviously you haven't checked the trials, phase 1 and phase 2, puts you 3-5 years out, plus you're assuming positive results. We'll check back in 12-16 months and let us all know.